STI Flashcards
(46 cards)
HIV modes of transmission
Sexual Parenteral Vertical
Pathophysiology of HIV
RNA retrovirus infect all cells expressing the T4(CD4) antigen -CD4 -B-cells -Macrophages Causes immunodeficiency, Autoimmunity, Allergic reactions
Progression of HIV to AIDS
AIDS is defined as a presence of an Opportunistic infections or CD4<200cells
Opportunistic infections with HIV/AIDS
Kaposi Sarcoma:Purple skin lesions Pneumocystis jeroveci:PNA, hypoxia, dry cough Toxoplasmosis: Focal neuro deficits, brain mass/lesion Cryptococcus neoformans: meningitis like picture(fungal) TB
CD4 count<500 OI
TB Kaposi Sarcoma
CD4 count<200 OI
Pneumocytosis Toxoplasmosis Cryptococcosis
CD4 count<50 OI
Disseminated MAC infection (Mycobacterium Adium complex) Histoplasmosis
Preferred HIV Test/screen
ELISA(HIV Enzyme Linked ImmunoSorbent Assay) 50%positive after 22 days 95% positive after 6 weeks Must be confirmed
Confirmatory Test for HIV
Western Blot Specificity when combined with ELISA>99.99% Indeterminate results with: -early HIV -HIV-2 -Influenza vaccine -Autoimmune disease -Pregnancy -Recent tetanus toxoid admin
Easy and quick test for HIV
HIV Rapid Antibody Test Screen for HIV, 10-20 minute results, performed with minimal training *Needs to be confirmed by ELISA and Western Blot
CBC in screening for HIV/AIDS
Anemia of chronic disease Neutropenia Thrombocytopenia(Advanced HIV infection)
Absolute CD4 lymphocyte count CD4 lymphocyte percentage
Most widely used predictor of HIV progression risk of progression to an AIDs OIis high with CD4 <200 or ,14% Folllowed Q3 months or sooner if change in status
Best test to help diagnose acute HIV infection
HIV viral load
HIV viral load test
Acute HIV diagnosis Correlate with. Disease progression Used to measure response to antiretrovirals
Screening criteria for HIV/AIDS
USPSTF recommends screening on adolescents and adults 15-65. Increase range if at increased risk Even if no risk recommend at least testing once No implied consent, make it clear ordering an HIV test
Goals of treatment for an HIV Pt
Viral Supression** OI prophylaxis Preventative considerations -cervical/rectal cancer screening -Vaccinations(Need CD4 count >200) -CAD and lipids -mental health/social support
When do you start antiretrovirals
As soon as the Pt is ready to start and be compliant, regardless of CD4 or viral count
Immune reconstitution
Immune system will rev up after antivirals are started and CD4 count starts to rise. It will begin attacking some bugs that it hadn’t and Pt’s might see symptoms(symptomatic support and reassurance)
Perihilar infiltrates-

Batwing appearance chest x-ray, of Pneumocystis jiroveci
Antiretroviral treatment should start asap because:
-Prevents further transmission -RCT’s x2 have proven benefit -additional health benefits(HIV virus does more damage than just immune system)
Antiretroviral drug selection based on:
-Viral genotype(resistance patterns) -Pt comorbid conditions *Pysch *Liver/renal disease *Hep B -Pt med interactions -Baseline viral load -HLA-B5701 status(Abacavir RXN) and G6PD RXN
Antiretroviral drug points to know
-Therapy must be 3 or more drugs(only 2 from same class) -Resistance is common(if Pt misses just a few doses virus can become resistant)
Nucleoside reverse transcriptase inhibitors (NRTIs or Nukes)
MOA-Prevent viral RNA from being transcribed into DNA Side Effects-associated with lactic acidosis, hepatic steatosis(fatty liver), and lipodystrophy(abnormal distribution of fat) Special-can also treat Hep B Monitor- Need to test for HLAB-5701 Abacavir Example-Emtricitabine
Non-nucleoside Revers transcriptase inhibitors (NNRTIs or Nonnukes)
MOA-Prevent viral RNA from being transcribed into DNA Side effects- rash(SJS) Has significant drug RXNs works best with viral load<100,000